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ABSTRACT 
 
In order to explore the molecular mechanisms of Herpes simplex encephalitis (HSE), a                                                         
severe infection of the central nervous system (CNS) caused by Herpes simplex type 1 
virus (HSV-1); a rat model resembling the human condition was characterized in the 
DA (Dark Agouti) strain. After injection into the whiskers’ area HSV-1 entered the 
CNS at the level of the brain stem via the trigeminal ganglion, subsequently spreading 
to the thalamus, cortex and olfactory bulb, leading to death at five days post infection 
(dpi). In contrast, the Piebald Virol Glaxo (PVG) strain was found to be completely 
resistant to disease and without signs of immunological reactions within the CNS, since 
HSV-1 virus did not penetrate beyond the site of inoculation. The kinetics of HSV-1 
infection in the two strains was thoroughly characterized by magnetic resonance 
imaging, quantitative polymerase chain reaction, virus isolation in green monkey 
kidney cells, histology and immunohistochemistry (IHC). 
 
Kinetics of virus propagation and primary immune reactions following HSV-1 
infection were compared between the susceptible DA and the resistant PVG strain at 12 
hours post-infection (hpi), 1, 2, 3 and 4 dpi. A low expression of Toll-like receptors 2 
and 9 and slower recruitment of macrophages was associated with viral replication in 
the perineurial cell layer and consecutive propagation to the CNS in the DA rats, while 
virus spread was confined to the epineurium of the peripheral nerve in the resistant 
PVG strain.  
 
The underlying genetic mechanisms for the difference in susceptibility between the two 
strains were dissected in a F2 (DAxPVG) intercross, with genome-wide microsatellite-
based genotyping. Linkage analysis revealed a very strong quantitative trait locus 
(QTL) on chromosome 4 regulating susceptibility to HSE. Fine mapping of the QTL by 
infection of additional rats with recombinations in the region, haplotype mapping of 
disease susceptibility in a panel of inbred rat strains, infection of congenic strains, 
sequencing and mRNA expression studies of the genes in the interval  indicated the 
calcitonin receptor (Calcr) as the candidate gene. Functional experiments with 
treatment using calcitonin receptor agonists in vivo provided further support of the 
candidate gene status of Calcr.  
 
Additional genetic determinants of susceptibility to HSE were studied in two other rat 
strains: Spontaneously Hypertensive Rat (SHR) and Brown Norway (BN), which are 
susceptible and resistant, respectively, to HSE, as well as in 29 BNxSHR recombinant 
inbred lines (RIL). The use of an already existing database of single nucleotide 
polymorphisms (SNPs) differing between SHR and BN revealed another significant 
QTL on chromosome 4 regulating susceptibility to HSE. Further analysis of the QTL 
using immunohistopathology indicated the Von Willebrand Factor homologue (Vwf) 
gene, which has a role in blood-brain-barrier homeostasis, as a possible candidate for 
regulating differences in susceptibility between the BN and SHR strains.  
 
In summary, the present study has demonstrated a strong genetic influence on the 
susceptibility to HSE in a rat model that displays many similarities to the corresponding 
human condition. Further genetic and functional studies are needed to confirm the 
candidate gene status of Calcr and Vwf regulating HSE and these may ultimately lead 
to more effective treatments of this severe CNS infection.  
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1 INTRODUCTION 
 
 
 
Herpes simplex encephalitis (HSE) is a relatively rare disease manifestation, although 
Herpes simplex virus (HSV) infections are ubiquitous all over the world. HSE is, 
however, the most common cause of non-epidemic, acute fatal encephalitis in the 
western world. To study it from pathogenesis to treatment demands reliable animal 
models. Recent studies show that unique, monogenic divergences rather than a general 
immunodeficiency can predispose people to rare infectious diseases. The present study 
comprises the characterization of a suitable animal model for the Herpes simplex type 1 
encephalitis and studies on the genetic regulation of the HSE pathogenesis and the early 
immune reactions related to it. 
 
 
1.1 THE DISEASE 
 
 
HSE is mostly caused by Herpes simplex virus type-1 virus (HSV-1) and in less than 10 
percent by Herpes simplex virus type-2 (Aurelius, Forsgren et al. 1993; Aurelius, 
Andersson et al. 1994). HSE is a rare disease, diagnosed in 2-3 individuals per million 
per year (Hjalmarsson, Blomqvist et al. 2007; Sancho-Shimizu, Zhang et al. 2007; 
Hjalmarsson, Granath et al. 2009). Before the introduction of the antiviral drugs, or 
without treatment, more than 70 % of the HSE affected died and most of the survivors 
had severe sequels. 
 
HSE may result from a primary, but more commonly from an earlier, reactivated HSV-
1 infection.  The age distribution of HSE differs from that of primary HSV-1 infection 
(Hjalmarsson, Blomqvist et al. 2007). 
 
Patients present with changed behavior, altered state of consciousness, with neuro-
radiological examinations revealing a focal inflammatory area in the medial part of the 
fronto-temporal lobe, usually unilaterally. Cerebrospinal fluid (CSF) findings include 
pleocytosis with predominantly lymphoid cells and increased number of red blood 
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cells. qPCR of the viral DNA from the CSF is the gold standard for diagnosis  and 
should be performed at the first symptoms which point towards encephalitis. 
 
Herpes simplex encephalitis is an 
acute inflammation characterized by 
edema and haemorrhage, most 
prominently in the temporal lobes, 
occurring most often 
asymmetrically in the adult patients 
(Boos and M.M. 1986) with the 
frequent involvement of the adjacent 
limbic system and the meninges 
overlying the temporal lobe being congested. The areas involved proceed to necrosis 
and liquefaction. At the earliest stage of the disease the histological changes are not 
dramatic and might not be specific for the condition. There is an evident congestion of 
the small vessels and of the capillaries in the cortex and the subcortical white matter 
with haemorrhagic necrosis (Booss and Kim 1984) and perivascular cuffing 
prominently in the second and third week of infection. Microscopic examination 
reveals that the involvement extends beyond the area that looks macroscopically 
abnormal. 
 
In untreated patients mortality caused by HSE is over 70 % and only 2.5 % of the 
survivors regain normal neurological function. HSE is treated by administration of 
Acyclovir administrated intravenously. Even with appropriate administration of 
antiviral therapy, there is substantial mortality and morbidity (Sköldenberg, Forsgren et 
al. 1984; Sköldenberg 1991; Studahl, Rosengren et al. 2000; Sköldenberg, Aurelius et 
al. 2006) with 19 % of the treated patients dying and 62 % of the survivors retaining 
some forms of neurologic sequels (Whitley, Alford et al. 1986). 
 
 
1.2 THE VIRUS 
 
 
Herpes simplex virus type 1 is a double-stranded DNA virus, belonging to the family of 
Herpesviridae, subfamily of Alphaherpesvirinae, genus of Herpes viruses. The virion 
consists of a large double-stranded linear DNA genome encased in an icosahedral 
 
MRI pictures of an HSE patient hospitalized in 
March (A), after treatment in June (B) and 
consequences of the encephalitis in October (C) 
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protein capsid, which is wrapped into an envelope composed of lipid bilayer with 
binding glycoprotein molecules integrated in it, connected to the capsid by the 
tegument.  
 
The infection of a host cell requires the binding of viral particles, i.e. glycoproteins on 
the envelope, to specific types of receptor molecules on the cell surface. The virion is 
thus internalised and dismantled, its capsid with the DNA migrates to the nucleus of the 
cell, the DNA being released into the cell nucleus, where replication and transcription 
of the viral genes take place. Entry of HSV-1 into the host cell involves interactions of 
several glycoproteins on the surface of the virus, with receptors on the surface of the 
host cell. The envelope covering the virus particle, when bound to specific receptors on 
the cell surface, will fuse with the host cell membrane and create an opening, or pore, 
through which the virus enters the host cell (Subramanian and Geraghty 2007). Viral 
envelope glycoprotein C (gC) binds to the cell surface heparan sulfate (WuDunn and 
Spear 1989; Spear, Shieh et al. 1992), glycoprotein D (gD) to at least one of the 
following cell receptor structures: Herpes virus entry mediator (HVEM), nectin-1 or 3-
O sulfated heparan sulfate (Cocchi, Fusco et al. 2004). Glycoprotein B interacts with 
glycosaminoglycans on the surface of the host cell. Once bound to the cell surface gD 
changes its conformation and interacts with viral glycoproteins H (gH) and L (gL), 
which form a complex. Afterwards, gB interaction with the gH/gL complex creates an 
entry pore for the dismantled viral capsid and some tegument proteins. These travel to 
the cell nucleus by the microtubules. The tegument proteins have role both in 
catalyzation of the transport process and in the uptake of the viral DNA into the cell 
nucleus through the nuclear pore.  
 
The infection can be asymptomatic when a small number of viral genes called latency 
associated transcript (LAT) accumulate, but the responsible mechanisms are largely 
unknown. 
 
In case of recurrent herpetic disease reactivation of latent viruses has been implicated.  
The transcription of LAT turns to the transcription of multiple lytic genes following 
activation, consequently replication and virus production are enhanced, which may lead 
to cell death. 
 
HSV-1, as all other Herpes viruses, is nuclear-replicating. In the infected cells the viral 
DNA is transcribed to RNA in the nucleus. 
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1.3 HSE MODELS 
 
 
The creation of a proper animal model for HSE is a major requirement for the 
possibility of studying the disease from early pathogenesis, immunological reaction, 
outcome, treatment, relapse etc. 
 
There have been many attempts to create a representative model for the human disease 
in rodents. However, most methods require a physical penetration of the blood-brain or 
blood-nerve barrier such as with intraparenchymal (Engel, Zhang et al. 2000) or 
intracerebroventricular (Ben-Hur, Itzik et al. 2004; Weidenfeld, Itzik et al. 2005) 
injection of the virus, injection into the vagus nerve (Thompson, Blessing et al. 2000) 
or injection of the HSV-1 into the eye (Cleator, Klapper et al. 1987). A newer, non-
invasive method is nasal instillation or dropping into the eye (without scarring); 
however, these routes of administration target other cranial nerves, the olfactory nerve 
or the optic nerve, not the trigeminus as in humans (Fujii, Akaike et al. 1999; Garssen, 
van der Molen et al. 2000; Solbrig, Adrian et al. 2006; Guo, Verdrengh et al. 2009). 
 
We have created a novel rat model 
which displays many features 
common with human HSE. Thus, 
after subcutaneous inoculation into 
the whiskers’ area the virus enters 
the trigeminal nerve and via the 
trigeminal ganglia penetrates the 
brain stem unilaterally on the 
ipsilateral side, propagating then in 
a contralateral and rostral direction. 
The probable cause of death in 
infected rats is likely to be the compromised brain stem functions.  
 
Notably, brain stem encephalitis has been described also in human subjects, with 
symptoms similar to the rats including progressive quadriplegia (Jereb, Lainscak et al. 
2005; Yoshidome, Hayashi et al. 2005; Miura, Kurita et al. 2009; Livorsi, Anderson et 
al. 2010).  
 
Injection of HSV-1 into the whiskers’ pad 
unilaterally under Isoflurane anaesthesia  
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2 AIMS OF THE STUDY 
 
 
 
The aims of the project have been to: 
 
- establish a model for HSE in the adult rat that as closely as possible mimics the 
human disease;  
 
- characterize the kinetics of the infection and immune activation;  
 
- study the degree of genetic influence on susceptibility to HSE in inbred rat strains, 
thereby shedding light on mechanisms of pathogenesis and finding new therapeutic 
targets. 
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3 CREATING A MODEL OF SUSCEPTIBILITY TO AND 
ONE FOR RESISTANCE AGAINST HSE 
 
 
 
In order to study basic mechanisms underlying susceptibility there was a need for 
creating a proper animal model. The ones described in the literature differ in many 
ways from the clinical condition. As most adult laboratory animals are resistant to 
HSV-1 infection, until now a row of different more or less invasive and drastic 
techniques have been used to infect the rodent CNS with HSV-1, such as injecting the 
virus into the vagus nerve (Thompson, Blessing et al. 2000), injecting it into the corpus 
vitraeum in the eye (Matsushima, Uyama et al. 1995), intraperitoneal (Fischer, Balk et 
al. 1976), by intraparenchymal (Engel, Zhang et al. 2000) or intracerebroventricular 
(Ben-Hur, Itzik et al. 2004; Weidenfeld, Itzik et al. 2005) injection etc.  
 
A recent, non-invasive method used by several groups is the nasal instillation of the 
virus into one (Jennische, Bergstrom et al. 2008) or both (Doorduin, Klein et al. 2010) 
nostrils or by drops into the eyes (Solbrig, Adrian et al. 2006). These methods are less 
invasive than the previous methods, but unlike human HSE they target the olfactory or 
the optical, instead of the trigeminal nerve. In order to imitate the human disease we 
sought to develop a reproducible method of injecting the virus unilaterally, on the right 
side into the whiskers’ area, targeting in this way the innervation area of the trigeminal 
nerve. This method would then allow for the study of pathogenic mechanisms for 
penetration of the virus into the nerve endings, the nerve fascicles and its further spread 
into the CNS, thereby giving a possibility of finding regulated gateways relating to 
HSE susceptibility.  
 
 
3.1 VIRUS STRAIN 
 
 
In order to create a proper model reflecting the features of the human disease virus 
strains with high infectivity and invasiveness in human patients were initially chosen.  
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The virus strain “F” originating from Professor Roizman’s laboratory, did not give 
clinical symptoms in the infected rats.  
 
We therefore proceeded to infect the rats with the highly neurovirulent I-2762 strain. 
This HSV-1 strain was isolated from a brain biopsy taken from a male patient on day 2 
after the onset of the first clinical symptoms of HSE. The patient died 2 days later as a 
consequence of the encephalitis (Sköldenberg, Forsgren et al. 1984).  The virus was 
propagated in green monkey kidney (GMK-AH1) cells for a maximum two passages 
and was aliquoted and stored at -80° C. The isolate was typed as HSV-1 by enzyme-
linked immunosorbent assay (ELISA) using type-specific monoclonal antibodies 
(mAbs) and infectivity titers were expressed in PFU/ml (Bergström and Lycke 1990). 
In previous experimental studies this strain showed a high degree of neurovirulence and 
neuroinvasiveness in both in vivo and in vitro (Bergström, Alestig et al. 1990; 
Bergström and Lycke 1990).  
 
 
3.2 LAB ANIMAL SPECIES 
 
 
Rabbits have long been used as animal models of human herpetic infections including 
encephalitis and have provided useful information on pathogenesis, prevention and 
therapy (Stanberry 1992).  
 
Studies of mouse models of HSE dating back to the sixties have significantly improved 
our knowledge of HSV-1 infection and HSE pathogenesis. Murine models of HSE have 
shown differences in susceptibility in diverse strains of mice (Lopez 1975; Kastrukoff, 
Lau et al. 1986; Ellison, Yang et al. 2000) and the influence of the age on susceptibility 
(Johnson 1964). Subsequent findings suggested that the natural resistance of the 
C57BL/6 strain compared to the susceptibility of the BALB/C strain might be 
conveyed by an enhanced interferon α/β response, however, only providing a transient 
delay in HSV-1 infection (Halford, Balliet et al. 2004). Attention has been lately 
returning to rats after the explosion of murine models in the golden era of development 
of the transgenic technologies in mice in the last decades. 
 
Rats are commonly used models in neuroscience and pharmacology. Nevertheless 
establishing a proper model for HSE in rats has been attempted in outbred rats, such as 
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Sprague-Dawley (Engel, Zhang et al. 2000) or in Wistar (Müller, Maharaj et al. 2005). 
One single study inverstigating ocular herpes has described strain differences in 
susceptibility towards HSV infection (Nicholls, Benylles et al. 1994), but this line of 
research was not pursued beyond the initial observation.  
 
 
3.3 LAB ANIMAL STRAINS 
 
 
In order to reduce experimental variability we decided from the start to work only with 
inbred rat strains established by at least 20 generations by brother-sister mating, the 
individuals of which are homozygous at all loci. As inbred Dark Agouti (DA) and 
Piebald Virol Glaxo (PVG) rats have been shown earlier to differ in their vulnerability 
to autoimmune neuroinflammation and their response to nerve injury (Holmdahl, 
Olsson et al. 1985; Lorentzen, Andersson et al. 1997; Weissert, Wallström et al. 1998; 
Lundberg, Lidman et al. 2001; Lidman, Swanberg et al. 2003; Abel, Plancoulaine et al. 
2010) these two strains were chosen initially.  
 
A first set of experiments 
demonstrated susceptibility in DA 
and resistance in PVG rats and 
further testing was subsequently 
performed in an extended set of 
inbred  rat strains, with the 
following being classified as 
susceptible: Lewis (LEW), Fisher 344 (F344), Spontaneously Hypertensive Rat (SHR) 
and Goto-Kakizaki type 2 diabetic rats (GK) with a similar disease phenotype as DA, 
and as resistant: Bio Breeding type 1 diabetic rats (BB) and Brown Norway (BN), 
having a similar resistance phenotype as PVG. Meanwhile other inbred strains were 
identified having intermediate phenotype, i.e. some individuals developed encephalitis 
while others presented only mild or no symptoms of disease at all, such as the August 
Copenhagen Irish (ACI), Wistar Furth (WF) and Fawn-Hooded (E3) rats. 
 
 
 
 
The susceptible DA and the resistant PVG rat 
(PVG.A) rats 
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3.4 SPECIAL LAB ANIMAL POPULATIONS 
 
 
To confirm or to exclude the influence of certain genes or chromosomal regions 
congenic populations can be used. The congenic lines are genetically identical to the 
background strain except for the gene or the genomic region which has been transferred 
by generations of breeding and backcrossing from another inbred strain. Thus, shortly 
after the establishment of the model we tested if the susceptibility/resistance in the DA 
and the PVG rat strains was conveyed by the MHC genes by infecting reciprocal 
congenics: DA rats carrying the MHC genes of the PVG rats (Dark Agouti-RT1
c
 DA) 
or a genetic fragment containing the Mhc2ta gene on chromosome 10 (DAc10PVG) 
and PVG rats carrying the MHC genes of the DA rats (Piebald Viral Glaxo-RT1
av1
 – 
PVG.1AV1, shortly referred to as PVG.A) and a reciprocal congenic of the 
chromosome 10 fragment (PVGc10DA) (Weissert, Wallström et al. 1998; Swanberg, 
Lidman et al. 2005). 
 
These experiments showed that neither the MHC complex nor the chromosome 10 
fragment regulated disease susceptibility. Since the PVG.A strain was as resistant to 
HSE development as the PVG strain, it was used in all further experiments.  
 
 
3.5 LAB ANIMAL AGE 
 
 
Age of the rats at the time point of the infection plays a crucial role in their 
susceptibility vs. resistance to develop HSE. Our model has been established in young 
adult animals. All DA rats infected with HSV-1 at the age of 45 days developed lethal 
HSE, while none of the PVG rats of the same age presented any clinical symptoms of 
disease. However, interestingly, 25 days old PVG rats were susceptible to HSE, while 
65 days old DA rats became resistant to disease development. The developmental 
aspect of susceptibility to HSE, most likely related to the development of some 
components of the innate immune responses has been described already in the sixties 
(Johnson 1964). 
 
In order to reduce a source of variability and to ensure reliability of data we infected the 
rats in all our experiments at the age of exactly 45 days.  
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3.6 ROUTE OF INFECTION 
 
 
In order to mimic as confidently as possible the route of HSV-1 propagation in patients 
and also to avoid invasive infection techniques we have chosen to inject the virus 
subcutaneously into the whiskers’ area, corresponding to the labio-facial area in 
humans most commonly affected by the virus.  
 
After being thawed to room temperature HSV-1 has been injected instantaneously s.c. 
into the area of the whiskers’ base on the right side unilaterally under 2 % Isoflurane 
anesthesia.  
 
The method enabled with great accuracy to compare the viral presence between the 
ipsi- and the contralateral side in the different anatomical compartments and to follow 
the chain of events from the uptake and propagation of virus from the infection site 
through the trigeminal ganglion on the ipsilateral side to the trigeminal nucleus in the 
brain stem, and the further spread of HSV-1 into the brain stem ipsilaterally, towards 
the contralateral side and its propagation in caudo-rostral direction to the thalamus, first 
to the contralateral, then to the ipsilateral side. One of the most interesting findings in 
this study was the completely different distribution of HSV-1, immunological cells and 
receptor expression in the different anatomical compartments (epi-, peri- and 
endoneurium) belonging to the peripheral nerves observed in DA vs. PVG rats. 
 
 
3.7 DOSE 
 
 
The use of the proper dose for infection has also shown to be of great importance. DA 
rats infected with doses as low as 10
6
 PFU HSV-1 did not develop HSE, while doses 
higher than 3 x 10
6
 seemed to increase survival, illustrating an extremely narrow, 
traditionally of virology point of view almost ignorable interval of doses, which most 
efficiently resulted in lethal encephalitis. Interestingly, in pilot experiments DA rats 
infected with higher doses developed clinical signs of encephalitis at day 5, then after 
three-four days started to recover and  regained weight, but after a couple of weeks fell 
sick and died in a relapse. This observation would be a very interesting starting point in 
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the future for a study focused on a more chronic, relapsing form of HSE (Sköldenberg, 
Aurelius et al. 2006).  
 
 
3.8 GENDER 
 
 
We have tested the model in both male and female rats and could show that there were 
no discernible differences in infectivity or disease outcome between the two genders. 
Thus, in most experiments, except for the genetic study we have used male rats in order 
to exclude variability which could originate in body weight differences or the changing 
hormonal levels and behavior depending on the estrus cycle in females.  
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4 VALIDATION OF THE MODEL 
 
 
 
Excluding all possible sources of variability and establishing a reliable and accurately 
reproducible model for both susceptibility and resistance we proceeded to their 
validation (Bereczky-Veress, Lidman et al. 2008). 
 
 
4.1 MAGNETIC RESONANCE IMAGING 
 
 
Non-invasive imaging methods give the 
possibility to follow the kinetics of the 
inflammation from the healthy, uninfected 
animal to the fully developed clinical 
disease in vivo. The T2-weighted RARE 
magnetic resonance imaging method is 
most commonly used for the detection of 
the brain pathogenesis caused by 
encephalitis and other similar conditions 
(Hennig, Nauerth et al. 1986). The method 
is based on measurements of water 
content, detecting changes in magnetic 
resonance properties of the tissues with 
edema caused by the inflammation compared to the healthy ones and transforms the 
information into images. We could visualize by this method that the encephalitis started 
in DA rats first in the brain stem at the level of the trigeminal nuclei on the ipsilateral 
side while PVG rats did not show signs of pathological changes of the brain at any time 
point. 
 
 
 
 
Magnetic resonance image of the brain stem 
showing oedema in DA rats compared to 
PVG 
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4.2 QUANTITATIVE POLYMERASE CHAIN REACTION 
 
 
To show distribution 
of viral spread from 
the infection site to 
the different 
compartments in the 
brain we performed 
qRT-PCR studies of 
the viral DNA in 
tissues sampled from 
infection site, i.e. the 
whiskers’ area, the 
trigeminal ganglia 
and five compartments of the brain, as brain stem, cerebellum, thalamus, cortex and the 
olfactory bulb (Namvar, Olofsson et al. 2005). In all compartments studied, except for 
the whiskers’ area, viral DNA was present in 103 – 105-fold higher quantity in DA rats, 
while in PVG rats only traces of HSV-1 DNA could be detected occasionally at 5 dpi. 
In the whiskers’ area HSV-1 DNA could be detected only in the ipsilateral side, in the 
trigeminal ganglia higher levels of viral DNA was present in the ipsilateral side and in 
the different segments of the brain there was no difference between viral DNA levels in 
the ipsi- and the contralateral side. Kinetic studies have shown that HSV-1 DNA was 
present in high levels in the whiskers’ area of both DA and PVG rats and in the 
trigeminal ganglia of the DA rats from 12 hpi to 5 dpi, while in the brain stem of DA 
rats levels increased from 2 dpi. No viral DNA was isolated from the trigeminal ganglia 
or the brain stem of the PVG rats. 
 
 
 
 
 
 
 
 
 
Significantly higher HSV-1 DNA copy numbers in the trigeminal 
ganglia and brain compartments of the DA rats 
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4.3 VIRUS ISOLATION 
 
 
Polymerase chain reaction 
detects viral DNA presence 
in the compartments studied, 
but does not give any 
indication regarding 
infectivity of the virus. We 
therefore performed virus 
isolation in green monkey 
kidney cells from the tissues 
of the whiskers’ area and of 
two compartments of the brain to study if living virus could be retrieved from these 
compartments. Interestingly, no living virus could be obtained from the whiskers’ area 
of neither DA, nor PVG rats at 5 dpi. In contrast, high levels of virus were obtained 
from the brain stem and the thalamus of the DA rats at 5 dpi, while these compartments 
in the PVG rat remained completely free of detectable virus. Kinetic studies showed 
that the quantity of infective HSV-1 decreased in the whiskers’ area in both strains 
within the first 2-3 days in parallel to an increase of replicating HSV-1 in the trigeminal 
ganglia and the brain stem solely in DA rats. 
 
 
4.4 IMMUNOHISTOCHEMISTRY 
 
 
Next, immunohistochemistry (Coons 1958; Pease 1962; Zamboni L. 1967) was used to 
gain a better understanding of the spread of the HSV-1 and the inflammatory process 
taking place in the brain. By staining different markers in tissue sections sampled from 
different compartments of the brain we have visualized HSV-1 penetration from the 
level of the trigeminal nuclei in the brain stem in rostral direction. The penetration of 
the HSV-1 was followed by a tissue reaction with infiltration of immunological cells. 
These two aspects of the encephalitis were shown by staining for activated microglia 
and astrocytes. OX6 is a MHC II marker expressed mainly on activated microglia and 
GFAP detects astrocytes. By staining of these two markers we proved that in DA rats 
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there was massive tissue activation compared to PVG rats, the brain of which remained 
as unaffected as that of the uninfected controls. 
Immunohistochemistry has also revealed the differences in the infiltration of the 
immune cells into the brain of the two HSV-1-infected rat strains. We could show that 
ED1
+
 phagocytic cells, NK cells, CD4
+
 T cells and CD8
+ 
T cells penetrated into the 
brain and invaded the HSV-1 infected areas while in the brains of PVG rats there was 
no infiltration of these cells (Dijkstra, Dopp et al. 1985). 
 
 
 
 
 
 
 
4.5 HISTOLOGY 
 
 
The traditional histology method of Hematoxylin-
Eosin staining visualizing the cell walls and the 
cell nuclei confirmed the conclusion drawn by 
immuno-histochemistry, i.e. severe tissue damage 
and many infiltrating cells were detected in the 
brain of the DA rats while no pathology of the 
brain was detected in the PVG rats. 
 
 
 
4.6 TUNEL-STAINING 
 
 
Apoptosis is an important component of the virus-
induced neuronal injury (Thompson 1995; Geiger, 
Nash et al. 1997; Griffin and Hardwick 1999; 
DeBiasi, Kleinschmidt-DeMasters et al. 2002; 
Perkins, Gyure et al. 2003; Pongpanich, 
Bhattarakosol et al. 2004; Huang, Lin et al. 2005; 
 
 
Infiltrating inflammatory cells  
in the brain stem of the DA rat 
Apoptotic cells in the brain stem of the DA 
Immunohistochemistry staining of the kinetics of HSV-1 spread in the brain stem of 
DA rats 
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Mori, Goshima et al. 2005; Sabri, Granath et al. 2006). The transferase-mediated dUTP 
nick-end labeling method is based on the labeling of the DNA strand breaks occurring 
in the apoptotic cells. Thus, TUNEL-staining is used to assess programmed cell death – 
apoptosis, an important aspect of the brain injury in HSE in the tissues. Our 
experiments have shown that apoptosis occurred in the HSV-1 infected brain stem of 
the DA rats; however no apoptotic activity was detected in the brain stem of the PVG 
rats. 
 
 
4.7 SCHEMATIC PICTURE OF THE HSE IN THE DA RATS 
 
 
 
 
 
 
 
 
Schematic picture of the kinetics of the HSV-1 penetration and the consecutive tissue reaction 
in the CNS of the DA rats (Paxinos and Watson 1998) 
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5 AIMS OF THE STUDIES BASED ON THE MODEL 
 
 
 
Once the model of susceptibility in DA and resistance in PVG strains has been 
characterized we found ourselves in front of a large palette of directions we could 
conduct our interest and studies towards. The field of research focusing on HSE 
pathogenesis and treatment is huge and in spite of decades of intensive research there 
are many questions still unanswered. 
 
 
5.1 EARLY IMMUNE REACTIONS RELATED TO HSE 
 
 
Our interest focused on studies regarding the differences in the ability of the innate 
immune system of the susceptible and the resistant rat strains to detect the viral agent 
respectively to mediate and provide immediate antiviral reactions.  We have explored 
the early kinetics of the HSV-1 infection and the consecutive host-dependent innate 
immune responses after 12 hours and each of the first four days post infection, 
demonstrating a lower and delayed ability in the susceptible DA strain to detect the 
virus as compared to the resistant PVG rats and that different anatomical compartments 
of the peripheral nerves got HSV-1 infected at the injection site in the two strains 
leading to the development of lethal encephalitis in the DA strain and to resistance in 
the PVG. 
 
 
5.2 GENETICS OF HSE 
 
 
In parallel to the immunological studies we started the most fascinating, but by far 
largest and time-demanding part of the study aimed at dissecting the genetic regulation 
of HSE. One of the most puzzling questions facing researchers is that why an immune 
competent person is affected by the disease, while others do not. By studying inbred 
strains, the individuals of which are genetically identical within the strain, but with 
large inter-strain differences, resulting in a completely different susceptibility pattern 
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towards a particular disease, we have the means to study the genetic involvement in the 
pathogenesis as these strains could be models for different human individuals.  
 
In this project we have made an attempt to identify genes regulating susceptibility to 
HSE by using the inbred rat strains and different populations of rats resulting from 
special breeding schemes established between the two strains. 
 
 
5.3 TREATMENT STUDIES 
 
 
We have conducted treatment studies in DA rats in order to attempt to attenuate disease 
outcome. In spite of the fact that these experiments generated a large amount of 
interesting and relevant data, the results are not included in this thesis, since further 
studies are needed for final conclusions. 
 
Preliminary results have shown that Acyclovir, currently used as a corner stone of HSE 
treatment in patients, remained the best treatment in the rat model too, while substances 
up-regulating early innate responses were not efficient, or even reduced the efficacy of 
Acyclovir. Interestingly, treatment with rat Interferon β, considered to have a beneficial 
role in HSV-1 infection (Olofsson, Holmberg et al. 2003; Halford, Balliet et al. 2004; 
Olofsson, Nerstedt et al. 2007) given at 1 and 3 dpi has caused death earlier when 
compared to untreated rats. As well, recent studies (Casrouge, Zhang et al. 2006) 
speculated that a deficiency in UNC-93 protein regulating intracellular TLR responses 
leading to reduced type I interferon production might be the genetic cause of 
susceptibility to HSE.  
 
It is known that immuno-compromised patients only develop subacute encephalitis. 
Our findings also support the notion that it is the immune reaction, not the HSV-1 
presence in the CNS per se, that is the main cause of the vast tissue damage leading to 
death in HSE. One of these findings is the worse outcome of the disease in the DA rats 
treated with Interferon β; another is the presence of HSV-1 in the CNS of the clinically 
resistant BN rats.  
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5.4 STUDIES OF THE SUBCLINICAL INFECTION  
 
 
Preliminary pilot studies by MRI have disclosed that chronic infection of the 
susceptible DA strain with subclinical dose of HSV-1 resulted in severe brain 
pathology in otherwise completely symptomless rats.  
 
Since the overweighing majority of the population is asymptomatic carrier of the HSV-
1 in the CNS, I believe that the study of the aspect of the subclinical infection would 
have been extremely interesting and could be observed in future through long-term 
experiments in vivo by the means of MRI. Unfortunately in lack of time we could not 
focus our attention onto this fascinating aspect.  
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6 EARLY IMMUNE RESPONSES TO HSV-1 
INFECTION IN HSE 
 
 
 
Innate immunity plays a crucial role in the control of HSV-1 infection (Wuest, Austin 
et al. 2006; Wuest and Carr 2008). The study has attempted to clarify the differences  in 
kinetics between the susceptible DA and the resistant PVG rats in the spread of the 
HSV-1, the tissue reaction and the immune cell infiltration to the virus affected 
compartments parallel to observations of the expression of a range of immune-related 
genes at the level of the infection site, the trigeminal nerve and the brain stem 
(Bereczky-Veress, Abdelmagid et al. 2010). The combination of the mRNA expression 
results obtained by qPCR at the molecular level and the immunohistochemistry 
findings at the cellular level offer satisfactory hints to give an insight to what might 
happen in the peripheral tissue after the penetration of the viral pathogen. 
 
qPCR analysis amplifying a sequence of a target of interest has been performed on 
cDNA made from the RNA extracted from the tissue samples from the whiskers’ area, 
trigeminal ganglia and the brain stem. The quantification was based on the comparison 
to the expression levels of commonly used housekeeping genes such as Gapdh and 
Hprt. 
 
Immunohistochemistry is based on the binding of a primary antibody to a target located 
of the marker to be studied. The binding was visualized by the binding of an 
immunofluorescence-labeled secondary species-different antibody to the primary one. 
There are other immunohistrochemistry methods which amplify the signal of the 
binding of the primary antibody, but these methods could not be used for the HSV-1 
infected tissues, because the virus-infected tissues bound the amplification substances 
unspecifically. 
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6.1 VIRUS DETECTION IN THE INFECTED ORGANISM 
 
 
Toll-like receptors are pattern recognition receptors of the innate immune system 
present on the surface and inside of many cell types detecting general, mostly well-
conserved characteristics of different classes of pathogens, as for example double-
stranded DNA or glycoproteins (Sarangi, Kim et al. 2007). 
 
Tlr2 and -9 play the most important role in recognizing viral envelope glycoproteins 
(Bsibsi, Ravid et al. 2002; Compton, Kurt-Jones et al. 2003; Krug, Luker et al. 2004; 
Boehme, Guerrero et al. 2006; Sato, Linehan et al. 2006; Sorensen, Reinert et al. 2008; 
Goethals, Ydens et al. 2010; Peltier, Simms et al. 2010), therefore we have investigated 
these molecules, in parallel to Tlr3 and -4. Indeed, we have found significantly reduced 
levels of Tlr2 and -9 in the susceptible DA rats at early time-points after infection 
compared to the resistant PVG rats, which were more efficient in detecting HSV-1 and 
could more rapidly signal further for adequate immune reaction. The role of Tlr2 and -9 
in the recognition of Herpes viruses has been demonstrated by in vitro experiments 
(Sato, Linehan et al. 2006). It has also been shown that these two receptors act 
synergistically (Sorensen, Reinert et al. 2008). The results obtained here suggest that in 
our double model of susceptibility vs. resistance the mRNA expression levels of these 
two Toll-like receptors at early time-points after infection play crucial part in allowing 
the viral pathogen to invade the CNS or to protect the host against the disease.  
 
On the other hand, defects in UNC-93 protein regulating intracellular TLRs and 
specifically TLR3, has been recently demonstrated to have a role in susceptibility to 
HSE (Casrouge, Zhang et al. 2006; Brinkmann, Spooner et al. 2007; Zhang, Jouanguy 
et al. 2007; Akashi-Takamura and Miyake 2008). In our model, on contrary, elevated 
levels of Tlr3 were detected at the infection site in the susceptible DA strain; therefore 
we assumed that susceptibility to HSE was not dependent on lack of Tlr3 in our model. 
 
 
6.2 THE SIGNALING 
 
 
Once the cell-associated pattern recognition receptors have detected the entry of the 
viral pathogen a cascade of events in the Tlr pathway is started. Adapter proteins (such 
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as Myeloid differentiation primary response factor 88 – Myd88) are recruited leading to 
enrollment and activation of protein kinases. This is followed by activation of different 
transcription factors (as Nuclear factor kappa B – Nfκb, Interferon regulatory factor 3 
and 7 – Irf3, Irf7), gene transcription and expression of proinflammatory cytokines 
(such as Tumor necrosis factor α – Tnfα, Il6), chemokines, endothelial adhesion 
molecules, costimulatory molecules and antiviral cytokines (as Interferon β – Ifnβ). 
 
In our study focusing on the early immune responses to HSV-1 infection we paid 
attention to the most important molecules involved in the signaling cascade. 
 
6.2.1 Adapter protein Myd88 
 
Comparing the mRNA expression of Myd88 in the susceptible DA and the resistant 
PVG rats we did not find differences at any compartment except for a minor difference 
in the expression in the brain stem (P ≤ 0.05) at 3 dpi. 
 
In an earlier study it has been shown Myd88 played a major role in the signaling 
cascade since Myd88
-/-
 mice were highly susceptible to lethal encephalitis (Mansur, 
Kroon et al. 2005).  
 
Considering that after infection Myd88 levels raised even in the trigeminal ganglia and 
the brain stem of the PVG rats, where the virus did not penetrate, we assumed that 
induction of this adapter protein occurs at a systemic level. In the view of the fact that 
there was no difference between the expression levels of this adapter protein between 
the DA and the PVG strains at any level, we could conclude that Myd88 did not play a 
role in the susceptibility vs. resistance to HSE in our model. 
 
6.2.2 The transcription factor Irf7  
 
Analysis of mRNA expression of Irf7 required in the Tlr signaling cascade (Honda, 
Yanai et al. 2005) revealed very high expression levels in both rat strains, with even 
higher levels in all anatomical compartments of DA rats (P ≤ 0.001). Thus, we could 
exclude the possibility that lack of expression in Irf7 might be the cause of the 
difference of susceptibility to HSE in the two rat strains. Results in mRNA expression 
levels of the transcription factor Irf3 were difficult to interpret and may be a 
consequence of low expression levels.  
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6.2.3 The inflammatory cytokines Tnfα and Il6 
 
DA rats expressed significantly higher mRNA levels of the pro-inflammatory cytokine 
Tnfα (P ≤ 0.001) in all the anatomical compartments studied, but these levels proved to 
be unprotective against HSE. Looking onto the cellular level, it has been shown that 
Tnfα penetrated the perineurium (Sorkin, Xiao et al. 1997; Bove, Weissner et al. 2009). 
This compartment has been proven in our study to have a special role in susceptibility 
to HSE.  
 
mRNA expression levels of Il6 did not differ between the two strains at the level of the 
whiskers’ area and were significantly higher in the trigeminal ganglia and the brain 
stem of the DA rats. Since HSV-1 did not penetrate into these compartments of the 
PVG rats we assumed that Il6 was expressed at local level where the HSV-1 was 
present and was not the cause of the susceptibility to HSE. 
 
6.2.4 The type I interferons, Infβ 
 
Recently it has been shown that interferon responses are important for HSE type 1 
(Jouanguy, Zhang et al. 2007; Zhang, Jouanguy et al. 2007). Similar mRNA expression 
levels of Infβ could be observed after infection in both rat strains in all anatomical 
compartments except for a difference in the brain stem at 4 dpi (P ≤ 0.05), when DA 
rats had higher values than PVG rats, which cannot explain differences in susceptibility 
to HSE, since HSV-1 did not penetrate into the CNS of the PVG rats. 
 
 
6.3 OBSERVATIONS AT THE CELLULAR LEVEL 
 
 
While qPCR reveals the mRNA expression of the target genes in the tissue as a whole 
at molecular level, immunohistochemistry enables to see the cellular compartment. 
Since we were aware from the validation of the model that HSV-1 did not penetrate 
into the trigeminal ganglia and the CNS of the PVG rats and did not bring about tissue 
reaction or immune cell infiltration in these compartments, our attention was focused 
primarily on the infection site. 
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6.3.1 At early time points HSV-1 infected small nerves in both strains 
 
In tissue sections sampled from the whiskers’ area at 12 hpi we detected similar spread 
of HSV-1, penetrating the epineurium of the nerve fascicles and in the immediate 
vicinity of small nerves in both strains. This might indicate that HSV-1 was present in 
the tissue at this time-point at the infection site, but that replication has not yet started, 
or still was on an initial stage in preferential cell types. 
 
6.3.2 After 1 dpi different distribution of HSV-1 in DA than in PVG 
 
The most exciting finding in the immunology study was the observation of the different 
spread of HSV-1 in the two rat strains. When validating the model we have described 
the kinetics of the HSV-1 in the whiskers’ area. We have shown by qPCR that viral 
DNA was present at constantly high levels in the whiskers’ area of both DA and PVG 
rats. By using virus isolation (virus culture) in green monkey kidney cells we stated 
also that infective HSV-1 was present at high levels in both DA and in PVG rats, 
decreasing rapidly at later time points from 10
5
 to 10
1
 PFU/ml in DA rats and from 10
4
 
to 0 PFU/ml in the PVG, but at the time of the characterization of the model had a poor 
understanding of what was happening at this level. 
 
After 1 dpi HSV-1 staining had a clearly 
distinguishable difference in spread in the 
whiskers’ area of DA and PVG rats. While 
in the PVG rats HSV-1 positivity was 
localized at all later time points in the outer 
part of the epineurium, in DA rats it spread 
to the perineurial layer glowing in a 
continuous ring-formed pattern around the 
nerve fascicles, with some traces of staining even in the endoneurium. This finding 
might indicate that the theory of the retrograde axonal transport of the virus vs. the 
transport through the cells of the perineurial layer towards the CNS has to be re-
evaluated.   
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6.3.3 Immune cell activation  
 
As HSV-1 did not penetrate either the peri- or endoneurium of the peripheral nerves, 
nor the trigeminal ganglia or the brain stem of the PVG rats, these compartments 
remained shielded from tissue reaction and immune cell infiltration. However in the 
whiskers’ area we observed by Iba1 and ED1 staining earlier phagocyting macrophage 
and dendritic cell recruitment (Smirkin, Matsumoto et al. 2010) in the PVG rats than in 
the DA. On the other hand in DA rats there was an earlier recruitment of NK and CD8
+
 
cytotoxic T-cell recruitment than in the resistant PVG strain leading also to an altered 
Schwann-cell morphology (Jessen and Mirsky 1984; Cheng and Zochodne 2002; 
Triolo, Dina et al. 2006). 
 
 
6.4 CONCLUSIONS REGARDING INNATE IMMUNE RESPONSES IN HSE 
 
 
In this study we have found different patterns of host defense against HSV-1 infection 
in the two strains. The DA rats presented lower levels of Tlr2 and -9 together with the 
earlier recruitment of NK and CD8
+
 cells and delayed engagement of macrophages as 
compared to the PVG rats which might indicate a weaker host defense facilitating 
HSV-1 entry to the peripheral nerves, replication and spread to the CNS. Nevertheless, 
the observation of the host strain-dependent differences in spread and replication of the 
HSV-1 in the perineurial cell layer might point towards the hypothesis, that the 
immunological differences between the two strains are more consequences of the 
infection and as a matter of fact the genetically determined characteristics of the 
perineurial cells play the decisive role in the viral entry to the CNS. 
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7 GENETIC STUDIES 
 
 
 
Once establishing a model of lethal susceptibility and a model of total resistance in two 
inbred rat strains our interest was directed towards the genetic aspect of disease 
regulation. 
 
 
7.1 GENETIC STUDIES IN DA AND PVG INBRED RAT STRAINS 
 
 
The first step in this study was to create an F1 intercross between the susceptible DA 
and the resistant PVG strain and to infect them at the age of 45 days. All individuals of 
the F1 generation, in which the genetic contribution of each parental strain is 50 %, 
were resistant to HSE development after infection. By crossing individuals of F1 with 
each other we accomplish the mendelian segregation of the genes of the two strains in 
the F2 generation. Infecting F2 individuals with HSV-1 we found 20 % of the rats to be 
susceptible to lethal HSE, and the rest surviving the infection without any clinical signs 
of the disease, except for a minor drop in some individuals in the body weight 
development curve at around 5 dpi, which we considered as being of intermediate 
phenotype. 
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7.1.1 Microsatellite marker-based genotyping 
 
Microsatellites are short repetitive segments of non-coding DNA named also variable 
number of tandem repeats (VNTRs). In a random population the numbers of the repeats 
in a microsatellite at a certain locus inherited from each parent differ, but in genetically 
distinct inbred lab animal populations, after many (at least 20) generations of brother-
sister mating all individuals are genetically identical, thus the number of the repeats of 
the microsatellite marker at a certain locus is also identical in each individual on both 
alleles. In another inbred strain the number of the repeats in a microsatellite marker can 
be different, but with all individuals within this strain sharing the same number of 
repeats on both alleles.  
 
This phenomenon of microsatellite polymorphism among different inbred strains 
allows for the tracing from which of the two parents genetic material has been inherited 
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in a F2 intercross. At a specific location this theoretically will result in 25 % 
homozygous for strain A, 25 % homozygous for strain B and 50 % heterozygous 
animals.  
 
The method is time consuming as one must identify a sufficient number of 
microsatellites throughout the whole genome and each animal has to be genotyped by 
qPCR for every microsatellite marker. Only in the initial experiment a total of 239 F2 
individuals were genotyped with 141 markers, resulting in 33,700 PCR reactions!  
 
7.1.2 Linkage analysis 
 
After crossing individuals of the F1 generation intercross we obtained an F2 cohort of 
239 rats of both genders, which were all infected at the age of 45 days and followed for 
body weight curve and disease development. F2 males showed 20 % of disease 
incidence, with an onset of the disease at 6 dpi, while female rats displayed a disease 
incidence of 10 % and slightly later onset of the disease at 8 dpi. 
 
A first round linkage analysis based on the 180 F2 individuals and 141 microsatellite 
markers calculated with the statistical software R 2.8.0 (Broman, Wu et al. 2003) 
identified a very strong linkage to a region on rat chromosome 4 regulating HSE 
incidence with a logarithm of odds/likelihood (LOD) (Laird, Zijderveld et al. 1991; 
Churchill and Doerge 1994; Jacob, Brown et al. 1995; Lander and Kruglyak 1995; Sen 
and Churchill 2001; Manichaikul, Dupuis et al. 2006) score of 29.5 and a confidence 
interval of 6.8 Mb. This quantitative trait locus (QTL) regulating HSE in our F2 cohort 
has been named Hse1. 
 
Adding phenotype observations and genotyping results of the rest of the F2 rats to the 
initially selected ones and performing further linkage calculations we found additional  
QTLs on other chromosomes regulating other aspects of the HSE phenotype such as 
date of onset of the disease, body weight loss between 4 an 5 dpi, between d 0 and 5 dpi 
etc. 
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7.1.3 Congenic lines confirm the confidence interval 
 
Congenic populations share the whole genome of the 
background strain except for a well-limited genomic 
region, which, by at least ten generations of microsatellite-
assisted selective breeding has been transferred from a 
strain with a different phenotype onto the background 
strain (Wakeland, Morel et al. 1997). In our lab there were 
already existing congenic lines having PVG genomic 
fragments bred onto DA background, but being 
homozygous for DA alleles in Hse1(Marta, Stridh et al. 
2010). We tested their susceptibility to HSE. All these 
congenic lines developed disease further supporting the disease regulatory effect of 
Hse1. 
 
7.1.4 Refining analysis: design of new microsatellite markers 
 
Once the main QTL was identified on a whole genome level, we could focus our efforts 
to further map polymorphisms found within the confidence interval. Thus, new 
microsatellite markers were designed, with re-typing of the initial cohort of rats as well 
as inclusion of a new cohort of rats enriched for individuals with recombinations within 
the CI. These efforts together reduced the confidence interval to around 1.01 Mb. 
 
7.1.5 Haplotype mapping 
 
Haplotypes are DNA sequences inherited together. In our case we refer by haplotype 
mapping to a comparison of genomic sequences, as defined by microsatellite 
genotypes, across different inbred strains. By comparing the degree of susceptibility 
with the pattern of genetic polymorphisms it is possible to find support for a disease 
regulatory role of certain regions within the CI of the QTL. More clearly: if two 
susceptible or two resistant strains are polymorphic for a certain genomic sequence 
within the interval, one can most likely rule out the role of that genomic sequence and 
focus on those, which are not polymorphic. In contrast, if comparing two strains, one 
susceptible and the other resistant, the underlying genetic polymorphism is likely to be 
localized in the genomic region which is polymorphic. 
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Thus, we have compared the genomic region consisting of the 1.01 Mb CI in a panel of 
inbred rat strains, some of which we have found to be susceptible (Lewis, Fisher 344, 
Spontaneously Hypertensive Rat and Goto-Kakizaki), resistant (Bio Breeding and BN) 
or to have an intermediate phenotype (August Copenhagen Irish, Wistar Furth and 
Fawn-Hooded) towards HSE development. The haplotype map reduced the confidence 
interval to a suggested 0.17 Mb, but also revealed the complexity of the genetic 
regulation of susceptibility to HSE, since the resistant BN strain had the genotype of 
the susceptible and intermediate strains within this region, while the susceptible GK 
shared genotype of the resistant PVG. 
 
7.1.6 Positioning the candidate gene 
 
After narrowing the confidence interval by further microsatellite markers, analysis of 
additional F2 rats and comparison to other inbred rat strains we proceeded to the 
sequencing of the genes within the CI. In this way we could rule out 6 out of the 9 
remaining genes, which did not differ between the two strains. 
 
Three remaining genes, Ccdc132, Calcr and Tfpi2 were found to have sequence 
polymorphisms between the DA and the PVG strain, but these were found on 
untranslated intronic or 5’ regions or were synonymous single nucleotide 
polymorphisms (SNP).  
 
To find which of these three genes is most likely the candidate for regulating incidence 
of HSE we proceeded to the comparison of the mRNA expression of these three genes. 
We did not find any difference in the mRNA expression of the Ccdc132 gene between 
the DA and the PVG rats. On the other hand in the mRNA expression of the Tfpi2 gene 
there were significant differences between the two strains only in the trigeminal ganglia 
and the brain stem, but not in the whiskers’ area. We therefore concluded that this 
might be a consequence of the infection rather than a cause, since in the whiskers’ area 
there were no differences in the expression of Tfpi2. 
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7.1.7 Congenic lines covering Hse1 
 
Breeding of congenic lines covering Hse1 is ongoing. 
Congenic rats having an insert of PVG sequence on 
chromosome 4 on a DA background, covering Hse1 have 
been infected. These congenic rats were all resistant to 
HSE development, further confirming the confidence 
interval. The PVG fragment on the DA background is still 
large; we aim to reduce by further breeding the size of the 
insert to Calcr. 
 
 
 
7.1.8 Calcitonin receptor gene as a possible candidate for regulation of 
HSE in DA rats 
 
The only gene, in which we found 
significant differences in the mRNA 
expression between DA and PVG rats in 
the whiskers’ area, was the calcitonin 
receptor Calcr gene (Pondel 2000; Ernst, 
Morgenthaler et al. 2007; Hamza, 
Higgins et al. 2007; Shen, Crotti et al. 
2007; Morfis, Tilakaratne et al. 2008; Naot and Cornish 2008). Interestingly, PVG rats 
had significantly higher expression of this gene both in naïve rats, vehicle-injected 
controls and HSV-1 infected rats at 2 and 4 dpi. 
 
7.1.9 Functional studies 
 
Once having a candidate gene for regulating HSE we turned to mechanistic studies to 
elucidate a possible disease regulatory effect of the calcitonin receptor. 
 
Cell culture studies have shown that both fibroblasts and neurons isolated from fetuses 
and from adults of both DA and PVG strains were equally susceptible to HSV-1 
infection. Neither treatment with rat Amylin, an agonist to the calcitonin receptor, nor 
treatment with CalcR antibodies influenced viral replication in the cells in culture. This 
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most likely indicates that the cross-talk of the cells among different cell-types in the 
living organism is of crucial importance for the protection against HSV-1 spread to the 
CNS. 
 
We therefore attempted to 
manipulate the calcitonin 
receptor and to influence 
disease outcome in vivo in 
infected rats. Thus we injected 
into the whiskers’ area of DA 
rats at the age of 44 days, i.e. 
one day prior to HSV-1 infection, different substances modulating calcitonin receptor 
signaling. Remarkably, survival of the susceptible DA rats was significantly improved 
after pre-treatment with calcitonin receptor agonist Rat Amylin and calcitonin receptor 
antagonist Calcitonin (8-32) Salmon I (Hilton, Dowton et al. 2000) as compared to 
controls injected with vehicle or with a scrambled peptide, that is, the Amylin amino-
acid sequence in reverse order. 
 
7.1.10 Conclusions regarding HSE regulation in DA and PVG rats 
 
We demonstrated in this study that the genomic region identified in an F2 cohort of 
intercross between the susceptible DA and the resistant PVG strain named Hse1, with 
Calcr as the main candidate gene, regulated susceptibility vs. resistance to HSE. 
Further studies will be needed to elucidate the role of CalcR in susceptibility to HSE in 
human studies and to put it in the focus of a therapeutic approach. 
 
 
7.2 GENETIC STUDIES IN BN-SHR RECOMBINANT INBRED LINES 
 
 
Studying susceptibility and 
resistance in different inbred rat 
strains we observed that BN rats 
were resistant to HSE in spite of 
the fact that they shared the DA 
genotype of the DA rats in the 
 
 
The resistant BN and the susceptible SHR rat  
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Hse1 region.  
In these experiments, another inbred rat strain, SHR, showed the same degree of 
susceptibility towards HSE as the DA rats. Our attention was drawn in an early stage 
upon a well characterized, SNP-genotyped panel of existing recombinant inbred rat 
lines existing in Prague and we have obtained rats from 29 of the existing 31 lines. 
 
Recombinant inbred lines result from an intercross of two different inbred rat lines. 
Individuals of the F2 generation are selected in pairs and their offspring is further bred 
by brother-sister mating for many generations, so that their genomes will contain a 
mixture of small fragments of the parental genomes, but homozygous for all the alleles, 
all individuals being genetically identical within the line, but different from the other 
line. 
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7.2.1 HSV-1 infected the CNS of the BN strain resistant to HSE 
 
Starting from the experience observed in PVG rats, that HSV-1 did not penetrate either 
into the peri- or endoneurium of the peripheral nerves, nor into the trigeminal ganglia or 
the brain stem, we were surprised by the very interesting immunohistochemistry 
finding, that HSV-1 was widely spread not only into the epi-, peri- and endoneurium of 
the peripheral nerves, but also into the trigeminal ganglia and the CNS of the BN rats. 
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Interestingly, the fact that BN rats were identical to DA rats in the Hse1 region 
corroborated this observation, however less immune cell infiltration could be observed 
in the brain stem of the BN than in the susceptible SHR rats. 
 
7.2.2 Phenotyping of the recombinant inbred lines 
 
We infected 45 day old rats of the 29 available inbred rat lines and observed them for 
disease incidence and development of the body weight curve. Five RILs did not present 
clinical symptoms of disease development, the rest got diseased at 3 – 5 dpi and the 
majority died at around 6 dpi. 
  
7.2.3 Linkage analysis of the results 
 
Genetic analysis of the phenotype results in the existing database (Pravenec, Klir et al. 
1989; Mueller, Goel et al. 2006; Atanur, Birol et al. 2010) has identified a significant 
QTL, Hse6 on chromosome 4 regulating disease incidence and weight loss between d0 
and 10 dpi, not identical with Hse1, besides additional suggestive QTLs on 
chromosomes 1, 9 and 10 as Hse7 and others. 
 
7.2.4 Identification of candidate genes 
 
Hse6 consists of approximately 220 genes, many of which are associated with immune 
regulation, especially that of the natural killer and dendritic cell function. Sequence 
comparison between the BN and the SHR genomes show over 7,000 SNP 
polymorphisms, 750 short insertions or deletions and 55 large deletions, but only 24 
genes can be identified with non-synonymous SNPs out of which only four are cis-
regulated (Leprecan-like 2, Vamp1, Vwf and RDG1562378), however Von Willebrand 
factor homolog gene, Vwf was the only one with mutation at the essential splice-site 
and had 2 non-synonymous mutations. Moreover, Vwf was cis-regulated in 6 tissues 
including the brain, while the RGD1562378 gene was not cis-regulated in the brain. 
 
7.2.5 Von Willebrand factor gene  
 
After identifying Vwf as a candidate for regulation of susceptibility vs. resistance in the 
parental SHR and BN strains and in the recombinant inbred lines between these two 
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strains we attempted to visualize differences in the parental strains by 
immunohistochemistry. 
 
Vwf is a protein synthesized in the endothelial cells and 
it is stored in the intracellular granules. It is a mediator 
between the blood vessel wall and the platelet and 
functions as an anti-hemophilic factor carrier facilitating 
hemostasis (Pendu, Terraube et al. 2006). It has also 
been shown to have an important role in preserving the 
integrity of the blood-brain barrier. 
In the whiskers’ area and the brain stem of the resistant 
BN rats Vwf staining clearly delineated the wall of the 
blood vessels restricting to a great extent penetration of 
the NK cells into the tissue as compared to the SHR rats 
in which Vwf positivity was less structured and NK 
cells were widely spread in the adjacent tissue (Kveberg, Jimenez-Royo et al. 2010). 
 
7.2.6 Conclusions regarding HSE regulation in DA and PVG rats 
 
Our study has identified HSV-1 spread to the CNS in both BN and SHR rats, however 
different pattern of NK cell penetration into the virus-affected compartments, 
supporting the hypothesis that differences in immune response to HSV-1 infection 
might play the major role in the development of HSE. 
Linkage analysis of the phenotypes observed in 29 RILs established between these rat 
strains revealed a significant QTL associated with HSE pathogenesis, with the Von 
Willebrand factor as a possible candidate gene. Further studies will be needed to study 
the role of Vwf in susceptibility to HSE at a molecular level and in patients in order to 
reveal if it is a candidate for therapeutic studies. 
 
 
 
 
 
 
 
 
Vwf and NK cell staining in  
the brain stem of BN and SHR 
SHR rats 
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8 CONCLUSIONS AND FUTURE PROSPECTS 
 
 
 
8.1 PAPER I 
 
 
Host strain-dependent difference in susceptibility in a rat model of Herpes simplex 
type-1 encephalitis. 
 
The establishment of a model of susceptibility vs. one of total resistance to HSE in two 
inbred rat strains has confirmed the utmost importance of the use of genetically well 
characterised strains of rats in particular and of laboratory animals in general. By 
choosing a well-defined HSV-1 strain, an optimal virus-dose, a new inoculation site 
targeting the trigeminal nerve, an optimal age of the rat at infection and inbred rat 
strains the novel HSE model was created. The new dichotome model has opened 
possibilities to study many aspects of HSE as pathogenesis, the role of the immune 
system in the disease development and the genetic regulation of the phenotypes.  
 
 
8.2 PAPER II 
 
 
Influence of Perineurial Cells and Toll-Like Receptors 2 and 9 on Herpes simplex 
Type-1 entry to the Central Nervous System in a Rat Model of Encephalitis. 
 
Compared to the resistant PVG rats low levels of virus detection by Tlr2 and Tlr9 at 
early time points after infection and slower recruitment of macrophages seem to be 
predisposing viral replication in the perineurial cell layer and its consecutive 
propagation to the CNS in the DA rats. The findings can serve as background to 
treatment studies. The different patterns of immune cell recruitment might be a 
consequence of the different mechanisms of HSV-1 spread in the periphery. The cause 
is more likely to be found in the genetically regulated differences in the properties of 
the cells in the perineurial layer within the two strains. 
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8.3 PAPER III 
 
 
Calcr is a candidate for regulation of susceptibility to Herpes simplex type-1 
encephalitis in the rat. 
 
Positioning Calcr as the main candidate gene of regulating HSE incidence in F2 
offspring of susceptible DA and resistant PVG cross might be an indication of an 
existing function permitting or restricting HSV-1 penetration to the CNS. Additional 
studies will be necessary to explain the mechanism of how calcitonin receptor interferes 
with HSE-1 at the molecular level. Once the mechanism understood, Calcr might be 
target of therapeutic intervention. Since most humans harbor HSV-1 in their sensory 
ganglia after the primary infection in the early childhood, further investigations will be 
needed to reveal if Calcr has any role in the development of HSE in patients, in 
preserving the large HSV-seropositive population from HSE or in maintaining a small 
part of the population HSV-seronegative throughout lifetime.  
 
 
8.4 PAPER IV 
 
 
Vwf is the candidate gene for regulation of susceptibility to Herpes simplex type 1 
encephalitis in rat recombinant inbred lines.  
 
Since HSV-1 penetrated after peripheral infection into the CNS of both susceptible 
SHR and resistant PVG rats, Vwf positioned as the candidate gene regulating 
susceptibility to HSE in these strains might also have a role in human HSE. Further 
studies will possibly reveal if an insufficiency in Vwf expression can explain why only 
a very small portion of the population harboring HSV-1 in their sensory ganglia 
develops HSE. 
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8.5 GENERAL CONCLUSIONS 
 
 
The results found using our rat model have shown the importance of the early innate 
immune responses in preventing encephalitis after peripheral infection as well as the 
specific cell types which might have a role in restricting or facilitating HSV-1 entry to 
the neural compartment. Two known genes have been also found in two different rat 
populations which most likely influence susceptibility to vs. resistance against HSE. 
Further studies using samples from HSE patients compared to appropriate controls are 
needed to test the relevance of our findings for the human condition. Genotyping 
studies in humans with HSE have revealed deficiencies in the expression of the 
intracellular UNC-93 protein and TLR3, leading to impaired Interferon β responses. 
Most likely, there are several genes of key importance for HSE development, the 
dysfunction of which alone or together can predispose to HSE under certain conditions.  
 
 
HSV-1 is a very complex ubiquitous virus and HSE is a rare disease. Therefore, in spite 
of huge efforts invested in their study throughout several decades, many questions for 
the pathogenesis of HSE have remained unanswered. It is very likely that neither the 
virus itself as in terms of latency, dose, neurovirulence etc. nor the host organism as in 
terms of genetics is alone responsible for the development of HSE, but both parts 
together contribute in variable proportions. A solution of the HSE puzzle will be the 
joint effort of scientists from the field of virology, immunology, genetics and others. 
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9 POPULÄRVETENSKAPLIG SAMMANFATTNING 
 
 
Herpes simplex virus, munsårsvirus infekterar i tidig ålder flertalet människor världen 
över och efter det finns viruset dolt kvar i nervknutar i organismen utan att orsaka några 
symptom. Olika faktorer som till exempel stress, mens eller sol kan göra att viruset 
aktiveras och bildar blåsor runt läpparna, så kallat munsår. Denna avhandling avser de 
sällsynta fall (ungefär 2-3 människor per million per år) där Herpes simplex virus 
orsakar en mycket svår hjärninflammation. Om sjukdomen upptäcks och kan 
diagnostiseras i tid, kan behandling med antivirala läkemedel, först och främst 
Aciclovir rädda livet hos de flesta patienterna, men neurologiska men från lindriga till 
mycket svåra förekommer ofta hos de överlevande. 
 
Målet med denna avhandling var att skapa en ny råttmodell för hjärninflammationen 
orsakad av Herpes simplex virus, att fördjupa sig i de mekanismer som styr den tidiga 
immunreaktionen efter perifer infektion samt att försöka förstå om ärftliga egenskaper 
hos värdorganismen kan styra resistens eller känslighet. 
 
Individer av inavlade råttstammar är lika som enäggstvillingar i sin arvsmassa, men 
skiljer sig väsentligt från andra inavlade stammar. Vi har funnit en råttstam, DA, som 
insjuknar i dödlig hjärninflammation efter infektion med Herpes simplex virus injicerat 
ensidigt i morrhårsområdet. Samtidigt har vi funnit en annan stam, PVG, som förblev 
resistent även efter infektion med mångdubbel dos av virus. Vi har beskrivit denna 
dubbla modell av känslighet/resistens med en lång rad metoder som sträcker sig från 
olika molekylärbiologiska metoder till virusodling från vävnad och 
magnetkameraundersökningar. 
 
DA och PVG råttstammarna har varit basen för uppföljningsstudier med vävnadsprover 
tagna 12 timmar och 1, 2, 3, 4 dygn efter virusinjektion. Vi undersökte särskilda 
molekyler som känner igen om viruset har kommit in i organismen och skickar vidare 
signaler till andra element av immunsystemet att agera och förgöra viruset och de redan 
angripna cellerna. I den känsliga stammen hittade vi mindre mängd av dessa molekyler 
i vävnadssnitten och som en följd skedde mobiliseringen av viktiga typer av 
immunceller också senare i dessa råttor. Utöver detta har vi kunnat konstatera att 
spridningen av viruset ägde rum på helt olika sätt i DA och PVG stammarna. Medan 
viruset i den känsliga stammen etablerade sig och infekterade cellerna som omgärdar 
och skyddar nerverna, kunde viruset i den resistenta stammen inte tränga sig in i 
närheten av dessa nerver. Resultaten pekar på att olika ärftliga egenskaper av cellerna 
runtom nerverna i de två råttstammarna skulle kunna bidra till sjukdomskänsligheten 
eller resistensen. 
 
Parallellt med detta projekt undersökte vi med andra metoder tecken på ärftliga faktorer 
som kunde bidra till skillnaden mellan DA och PVG. Vi har korsat dessa två 
råttstammar och konstaterat att första generationen avkomma är totalt resistent, medan 
en fjärde - femtedel av andra generationen avkomma blir sjuk och resten förblir 
motståndskraftig. Vi har noterat vilka av dessa råttor som blev sjuka och vi har 
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analyserat vävnadsprover för att iaktta arvsmassan hos varje råtta. Individer i den andra 
generationen har slumpmässigt ärvt en del av sin arvsmassa från den ena, och resten 
från den andra stammen. Det finns markörsekvenser i arvsmassan som annars inte 
spelar någon roll för ärftligheten, men som skiljer sig storleksmässigt mellan de olika 
inavlade stammarna. Med hjälp av dessa sekvenser har vi kunnat identifiera vilka 
fragment av arvsmassan som ärvts från DA och vilka från PVG råttor hos de olika 
individerna av den andra generationen. Dessa data matades in i en specialskapad 
datormjukvara som har funnit vilken del av arvsmassan som möjligen styr 
sjukdomsmottagligheten. Denna del av arvsmassan innehåller en rad gener. För att 
exakt kunna finna vilken av dessa gener som kan orsaka Herpes simplex 
hjärninflammation (HSE) har vi jämfört våra data med en lång rad andra inavlade 
stammar och med hjälp av andra avancerade molekylärtekniska metoder kunde vi 
föreslå en gen, calcitonin receptor genen, som en möjlig kandidat för boven i dramat. 
Vi bekräftade sannolikheten av att calcitonin receptor genen styr 
sjukdomsmottagligheten genom att före infektionen behandla råttorna med olika 
substanser som påverkar receptorn. Dessa substanser har höjt överlevnaden till 75 % 
hos behandlade och infekterade råttor jämfört med 0 % hos icke-behandlade, 
infekterade råttor av den känsliga stammen DA. Hypotesen kommer att bekräftas 
ytterligare med hjälp av speciellt avlade DA råttor, som i sin arvsmassa bara kommer 
att ha calcitonin receptor genen från den resistenta PVG stammen. Ifall dessa råttor 
förblir skyddade från hjärninflammation, bekräftar detta calcitonin receptor genens roll 
i åkomman. 
 
Andra inavlade råttstammar kan också vara känsliga eller resistenta för Herpes simplex 
virus orsakad hjärninflammation. Vi har undersökt en annan population av korsning 
mellan den känsliga SHR och den resistenta BN stammen också, bestående av olika 
linjer som har inavlats under mer än 60 generationer. Arvsmassan av dessa linjer är 
redan väl dokumenterad vad gäller bidraget av de ursprungliga stammarna i deras 
arvsmassa. Genom att undersöka sjukdomsutvecklingen efter infektion i dessa linjer 
och analysera resultaten i en annan redan existerande datormjukvara kunde vi 
identifiera en klump av gener som möjligen har roll i regleringen av immunsystemet 
och känsligheten för hjärninflammationen. Vi har sedan uteslutit de flesta av dessa 
gener som inte kan vara bidragande och har slutligen identifierat en annan kandidatgen 
som också kan spela roll i ärftligheten av känslighet. Denna nya gen bildar ett protein, 
von Willebrand faktor homolog, som har en roll i att skydda hjärnans integritet mot 
penetrerande, skadliga immunceller. 
 
Våra resultat ger oss en bild av vad som händer efter infektionen med Herpes simplex 
virus på molekylär- och vävnadsnivå och öppnar möjligheten att kunna studera om det 
hos människor är samma gener som hos råttor som kan leda till sjukdomsutveckling. 
Ifall dessa geners roll också kan bekräftas hos patienter med Herpes simplex virus 
orsakad hjärninflammation, kommer vi att ha en stark utgångspunkt för att med hjälp 
av modellen kunna utveckla bättre läkemedel och terapeutiska metoder för behandling 
av sjukdomen. 
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